567 results on '"Bemelman, Frederike J."'
Search Results
2. Rescue Allocation Modes in Eurotransplant Kidney Transplantation: Recipient Oriented Extended Allocation Versus Competitive Rescue Allocation—A Retrospective Multicenter Outcome Analysis
3. Cardiovascular risk in ANCA-associated vasculitis: Monocyte phenotyping reveals distinctive signatures between serological subsets
4. Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA
5. Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease: A nested case-control study
6. NKp44/HLA-DP-dependent regulation of CD8 effector T cells by NK cells
7. mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses
8. Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity
9. Th1-dominant cytokine responses in kidney patients after COVID-19 vaccination are associated with poor humoral responses
10. Risk factors for neurocognitive impairment and the relation with structural brain abnormality in children and young adults with severe chronic kidney disease
11. Clinical triage of patients on kidney replacement therapy presenting with COVID-19: an ERACODA registry analysis
12. Comparison of 2 Immunosuppression Minimization Strategies in Kidney Transplantation: The ALLEGRO Trial
13. Considerable Variability Among Transplant Nephrologists in Judging Deceased Donor Kidney Offers
14. The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients
15. Adherence to preventive measures after SARS-CoV-2 vaccination and after awareness of antibody response in kidney transplant recipients in the Netherlands: a nationwide questionnaire study
16. Traditional and disease-related cardiovascular risk factors in ANCA-associated vasculitis: A prospective, two-centre cohort study
17. Comparison of 2 Immunosuppression Minimization Strategies in Kidney Transplantation: The ALLEGRO Trial
18. Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine (RECOVAC): a randomised clinical trial
19. Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective: Results of the CUREiHUS Study
20. The effect of COVID-19 vaccination on kidney function and HLA antibody formation in patients with end-stage kidney disease and on kidney replacement treatment
21. Structural brain abnormalities in children and young adults with severe chronic kidney disease
22. Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenue
23. Donor characteristics and their impact on kidney transplantation outcomes: Results from two nationwide instrumental variable analyses based on outcomes of donor kidney pairs accepted for transplantation
24. Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies
25. Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study
26. Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases
27. Deep learning-based classification of kidney transplant pathology: a retrospective, multicentre, proof-of-concept study
28. Alkaline phosphatase treatment of acute kidney injury—an update.
29. Infiltrative classical monocyte-derived andSPP1lipid-associated macrophages mediate inflammation and fibrosis in ANCA-associated glomerulonephritis
30. The effect of genetic variants in the transcription factor TSPYL family on the CYP3A4 mediated cyclosporine metabolism in kidney transplant patients
31. Clinical Remission and Reduction of Circulating Nephritic Factors by Combining Rituximab With Belimumab in a Case of Complement Factor 3 Glomerulopathy
32. Cardiovascular risk in ANCA-associated vasculitis: monocyte phenotyping reveals distinctive signatures between serological subsets
33. Determination of the clinical relevance of donor epitope‐specific HLA‐antibodies in kidney transplantation
34. SARS-CoV-2 Spike-specific IFN-γ T-cell Response After COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant
35. Predictors of Nonseroconversion to SARS-CoV-2 Vaccination in Kidney Transplant Recipients
36. Kidney Transplantation and Diabetic Nephropathy
37. A nationwide evaluation of deceased donor kidney transplantation indicates detrimental consequences of early graft loss
38. The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant
39. Rescue Allocation Modes in Eurotransplant Kidney Transplantation: Recipient Oriented Extended Allocation Versus Competitive Rescue Allocation—A Retrospective Multicenter Outcome Analysis
40. Antibodies against ARHGDIB are associated with long-term kidney graft loss
41. Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment
42. Equivalent Long-term Transplantation Outcomes for Kidneys Donated After Brain Death and Cardiac Death: Conclusions From a Nationwide Evaluation
43. Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients.
44. The role of interleukin-21 in COVID-19 vaccine–induced B cell–mediated immune responses in patients with kidney disease and kidney transplant recipients
45. Adherence to preventive measures after SARS-CoV-2 vaccination and after awareness of antibody response in kidney transplant recipients in the Netherlands: a nationwide questionnaire study
46. Association of obesity with 3-month mortality in kidney failure patients with COVID-19
47. Intercontinental Deceased-donor Kidney Transplantation in Dutch Antilleans: Favorable Outcomes Despite Prolonged Ischemia
48. Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection
49. Alkaline phosphatase to treat ischaemia–reperfusion injury in living‐donor kidney transplantation: APhIRI I feasibility pilot study.
50. Cognitive Improvement After Kidney Transplantation Is Associated With Structural and Functional Changes on MRI
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.